# Pearl vs Lunit

Pearl records 221,155 monthly visits with -7.6% month-over-month growth and Contact for Pricing pricing. Lunit records 29,181 monthly visits with -12.8% growth and Contact for Pricing pricing.

| Metric | [Pearl](https://openaitools.app/tool/hellopearl-com) | [Lunit](https://openaitools.app/tool/lunit) |
| :--- | :--- | :--- |
| Website URL | https://hellopearl.com | https://www.lunit.io/en |
| Categories | AI Healthcare, AI Medical Diagnosis, AI Image Recognition, AI Detector | AI Healthcare, AI Medical Diagnosis, AI Image Recognition |
| Pricing Model | Contact for Pricing | Contact for Pricing |
| Monthly Visits | 221,155 | 29,181 |
| MoM Growth Rate | -7.6% | -12.8% |
| Primary Market | United States | South Korea |
| Direct Visits | 144,018 | 8,314 |
| Review Score | 4.5 | 4.6 |
| Saved Count | 0 | 1 |
| Supported Platforms | Website | Website |

## Pearl

Pearl is a clinical-grade dental AI suite built for the everyday workflow of a dental office. Its flagship product, Second Opinion, applies computer vision to 2D radiographs and 3D CBCT volumes to flag findings such as caries, bone loss, calculus and periapical issues that a clinician might miss during a routine review. Because it has secured regulatory clearances for both 2D and 3D diagnostic support, it is positioned as a chairside second reader rather than a marketing gimmick.

Beyond diagnostics, Pearl bundles practice-management capabilities. Practice Intelligence aggregates production, coding and clinical data to show owners and DSO operators where care is being missed or revenue is leaking. RCM takes on insurance verification and claim preparation, while Calibrate uses the same AI engine to train and assess clinicians with guided feedback. Pearl Voice adds ambient documentation for clinical notes and periodontal charting.

The company says its tools are used by more than 29,000 practices across 120+ countries, with dozens of integrations into common imaging and practice-management systems and more than two dozen regulatory clearances. Deployment is consultative: interested offices book a demo, and pricing is quoted per practice, so specific figures are not published publicly.

**Pricing & Plans:** Pearl does not publish list prices. Interested dentists, DSOs and universities book a demo or contact sales for a per-practice quote based on modules and integrations.

- **Second Opinion radiologic AI:** Computer-vision detection of pathologies on intraoral and panoramic X-rays, plus a 3D edition for CBCT review by specialists and general dentists.
- **Practice Intelligence analytics:** Turns production, coding and clinical records into dashboards that reveal missed treatment opportunities and operational bottlenecks.
- **RCM insurance workflow:** Automates insurance verification and helps build cleaner claim submissions to reduce denials and speed up the revenue cycle.
- **Calibrate clinical training:** Uses AI-guided feedback to standardise diagnostic decisions across a team and help new clinicians build confidence.
- **Pearl Voice documentation:** Ambient voice AI that drafts clinical notes and assists with periodontal charting so clinicians spend less time at the keyboard.

**Strengths:** Regulatory clearances cover both 2D radiographs and 3D CBCT, which is rare among dental AI vendors; Combines diagnostics with practice analytics, revenue-cycle and training tools in one stack; Broad imaging and practice-management integrations plus a large global install base; Clear patient-facing visualisations that support informed consent conversations

**Limitations:** No public pricing; every deployment starts with a sales demo and custom quote; Full value depends on integrating with existing imaging and PMS software, which varies by region; AI findings still require a licensed clinician's judgement and cannot be treated as a final diagnosis

[Profile (Markdown)](https://openaitools.app/tool/hellopearl-com.md)

## Lunit

Lunit is a medical AI company headquartered in Seoul, South Korea, spun out of deep-learning research and focused squarely on oncology. Rather than chasing general-purpose healthcare AI, it has built two connected product families: one that helps clinicians find cancer earlier in imaging, and one that extracts quantitative biology from tissue to guide treatment and drug development. Its technology is used across a large international footprint spanning more than 10,000 customer sites in over 70 countries, with hundreds of peer-reviewed publications and industry partnerships behind the deployments.

On the screening side, the Lunit INSIGHT family analyzes mammograms and chest radiographs. Lunit INSIGHT MMG handles 2D mammography while Lunit INSIGHT DBT covers 3D breast tomosynthesis, both designed to flag suspicious regions so radiologists can prioritize the studies that need attention most. Lunit INSIGHT CXR does the same for chest X-rays. Around these detection engines Lunit has assembled program-level tooling: density assessment, risk assessment and risk pathways, live mammography reporting, quality management, analytics, and a patient hub, so a screening service can run AI as part of its routine rather than as an isolated experiment.

On the precision oncology side, the Lunit SCOPE portfolio analyzes pathology images. Lunit SCOPE IO quantifies the tumor microenvironment and immune cell infiltration, which matters for immunotherapy strategy, while the Lunit SCOPE IHC Suite supports immunohistochemistry quantification across markers such as HER2 and PD-L1, alongside a genotype prediction tool. These products are aimed at biopharma partners, clinical trial teams, and companion diagnostic development, where reproducible quantitative readouts are the bottleneck. Because Lunit sells to hospitals, screening programs, and pharmaceutical companies, pricing is quoted directly rather than published, and regulatory status differs by market.

**Pricing & Plans:** Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered.

- **Lunit INSIGHT MMG and DBT:** Deep-learning analysis of 2D and 3D mammography that marks suspicious lesions to help radiologists detect breast cancer earlier and reduce missed findings.
- **Lunit INSIGHT CXR:** Chest X-ray analysis that highlights potential abnormalities such as nodules and other findings, supporting faster triage in high-volume radiology workflows.
- **Lunit SCOPE IO:** Tumor microenvironment analysis that quantifies tumor-infiltrating lymphocytes and immune phenotypes from pathology slides, informing immunotherapy research.
- **Lunit SCOPE IHC Suite:** AI-assisted immunohistochemistry quantification covering HER2, PD-L1, and other markers, including uIHC and a gene-expression prediction tool for standardized scoring.
- **Screening analytics and workflow tools:** Live mammography reporting, risk assessment, risk pathways, quality management, and patient-facing tools that embed AI into the wider screening program.

**Strengths:** Clinically validated radiology AI with documented regulatory clearances and published evidence; Covers two ends of the cancer pathway — screening detection and precision oncology biomarkers — in one vendor relationship; Wide real-world adoption across many countries, which means integrations and workflow lessons already exist; Strong research output and biopharma partnerships support credibility for trial and CDx work

[Profile (Markdown)](https://openaitools.app/tool/lunit.md)

## Frequently Asked Questions

### How do Pearl and Lunit compare in monthly traffic?

Pearl has 221,155 monthly visits, while Lunit has 29,181. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Pearl has a month-over-month growth rate of -7.6%; Lunit has -12.8%.

### How does pricing compare?

Pearl: Contact for Pricing. Pearl does not publish list prices. Interested dentists, DSOs and universities book a demo or contact sales for a per-practice quote based on modules and integrations. Lunit: Contact for Pricing. Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [ScanSkinAI](https://openaitools.app/tool/scanskinai) | 265,770 | -10.9% | Freemium, Paid | Free AI skin and mole scanning with optional dermatologist review | [.md](https://openaitools.app/tool/scanskinai.md) |
| 2 | [Overjet](https://openaitools.app/tool/overjet-ai) | 256,150 | +12.6% | Contact for Pricing | FDA-cleared dental AI for diagnostics, imaging, and insurance workflow | [.md](https://openaitools.app/tool/overjet-ai.md) |
| 3 | [0xmd](https://openaitools.app/tool/0xmd-com) | 128,262 | -2.2% | Freemium | Generative AI for medical and everyday health questions | [.md](https://openaitools.app/tool/0xmd-com.md) |
| 4 | [Skinive AI](https://openaitools.app/tool/skinive-ai) | 111,143 | -30.9% | Freemium | Dermatology-focused AI screening app evaluating smartphone photos of skin concerns for multiple conditions. | [.md](https://openaitools.app/tool/skinive-ai.md) |
| 5 | [CT Read](https://openaitools.app/tool/ct-read) | 103,157 | -5.8% | Paid | AI analysis that turns X-rays, CT scans, MRI and ultrasound into plain-language reports | [.md](https://openaitools.app/tool/ct-read.md) |
| 6 | [Glass Health](https://openaitools.app/tool/glass-health) | 41,068 | -52.2% | Contact for Pricing | Frontier clinical AI grounded in leading medical evidence | [.md](https://openaitools.app/tool/glass-health.md) |
| 7 | [Oatmeal Health](https://openaitools.app/tool/oatmeal-health) | 40,264 | -44.9% | Contact for Pricing | AI lung cancer screening that finds eligible patients and scores every nodule | [.md](https://openaitools.app/tool/oatmeal-health.md) |
| 8 | [RapidAI](https://openaitools.app/tool/rapidai-com) | 20,172 | -27.9% | Contact for Pricing | Enterprise clinical AI that turns medical imaging into faster, more confident care decisions. | [.md](https://openaitools.app/tool/rapidai-com.md) |
| 9 | [Healz.AI](https://openaitools.app/tool/healz-ai) | 12,433 | -47.4% | Freemium, Free Trial, Paid | AI case review for cancer and complex conditions, with human oncologists in the loop | [.md](https://openaitools.app/tool/healz-ai.md) |
| 10 | [Ibex Medical Analytics](https://openaitools.app/tool/ibex-ai-com) | 9,117 | -3% | Contact for Pricing | AI-powered cancer diagnostics that help pathologists detect disease earlier and more accurately. | [.md](https://openaitools.app/tool/ibex-ai-com.md) |

---
Source: https://openaitools.app/compare/hellopearl-com-vs-lunit

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)